MiLaboratories

MiLaboratories is a private, platform-focused biotech company that has established itself as a provider of sophisticated computational biology tools for immunology research. Founded in 2015 and headquartered in Barcelona with a corporate presence in San Francisco, the company caters to the growing need for analyzing complex immune repertoire data. Its core business model revolves around licensing its software platform and associated services to academic and commercial researchers. The company is in a revenue-generating stage, leveraging its technology to serve the rapidly expanding fields of immuno-oncology, infectious disease research, and autoimmune disorder studies.

Cloud-based computational biology platform (VDJ.online) for the analysis of immune receptor repertoire sequencing data, specializing in V(D)J recombination analysis for T-cell and B-cell receptors.

MiLaboratories competes in a crowded bioinformatics segment, facing competition from large, diversified tools companies (e.g., Illumina, Qiagen, Thermo Fisher), specialized software startups (e.g., Adaptive Biotechnologies' immunoSEQ platform, 10x Genomics), and freely available academic pipelines. Its differentiation lies in its specialized focus, user-centric online platform, and active engagement with the research community.